Recombinant Hyaluronidase Market to Reach USD 1.6 Billion by 2032: 9.8% CAGR Fueled by Biologics Delivery and Aesthetic Medicine Demand The global Recombinant Hyaluronidase Market is expanding rapidly due to rising demand in drug delivery, oncology therapies, and aesthetic medicine. In 2023, the market was valued at approximately USD 720 million, with global sales volumes surpassing 38 million vials. Industry projections indicate a compound annual growth rate (CAGR) of 9.8% between 2024 and 2032, which could push the market to nearly USD 1.6 billion by 2032. Read Full Research Study: https://marketintelo.com/report/recombinant-hyaluronidase-market